Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Albrecht

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Clinics in Dermatology|December 23, 2019
Erythema elevatum et diutinum as a systemic diseaseJeena K Sandhu, Joerg Albrecht, Gaurav Agnihotri, et al.
The British Journal of Dermatology|November 18, 2025
From significance to relevance: raising the bar for harm in dermatologyJoerg Albrecht, Jo Leonardi-Bee, Sonia Gran, et al.
JAMA Dermatology|January 24, 2019
Evaluation of Clinical Compendia Used for Medicare Part D Coverage Determinations for Off-label Prescribing in DermatologyJohn S Barbieri, Kayla St Claire, Arash Mostaghimi, et al.
JAAD Case Reports|November 19, 2025
Oral plasma cell mucositisJahleel Perrin, Hiren Kolli, Brigitte Utter, et al.
The British Journal of Dermatology|August 20, 2022
Is routine laboratory testing in healthy young patients taking isotretinoin necessary: a critically appraised topicAndrew Affleck, David Jackson, Hywel C Williams, et al.
Journal of the American Academy of Dermatology|September 18, 2017
Prior authorizations for dermatologic medications: An American Academy of Dermatology survey of US dermatology providers and staffAaron M Secrest, Maryam M Asgari, Arianne S Kourosh, et al.
Archives of Dermatology|March 18, 2009
Lenalidomide for the treatment of resistant discoid lupus erythematosusAsha Shah, Joerg Albrecht, Zuleika Bonilla-Martinez, et al.
Archives of Dermatology|January 23, 2008
Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgarisVictoria P Werth, David Fivenson, Amit G Pandya, et al.
Archives of Dermatology|August 20, 2008
Quality of life and disease severity in a cutaneous lupus erythematosus pilot studyElizabeth Gaines, Zuleika Bonilla-Martinez, Joerg Albrecht, et al.
Archives of Dermatology|February 20, 2008
The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosusZuleika L Bonilla-Martinez, Joerg Albrecht, Andrea B Troxel, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Clinics in Dermatology|December 23, 2019
Erythema elevatum et diutinum as a systemic diseaseJeena K Sandhu, Joerg Albrecht, Gaurav Agnihotri, et al.
The British Journal of Dermatology|November 18, 2025
From significance to relevance: raising the bar for harm in dermatologyJoerg Albrecht, Jo Leonardi-Bee, Sonia Gran, et al.
JAMA Dermatology|January 24, 2019
Evaluation of Clinical Compendia Used for Medicare Part D Coverage Determinations for Off-label Prescribing in DermatologyJohn S Barbieri, Kayla St Claire, Arash Mostaghimi, et al.
JAAD Case Reports|November 19, 2025
Oral plasma cell mucositisJahleel Perrin, Hiren Kolli, Brigitte Utter, et al.
The British Journal of Dermatology|August 20, 2022
Is routine laboratory testing in healthy young patients taking isotretinoin necessary: a critically appraised topicAndrew Affleck, David Jackson, Hywel C Williams, et al.
Journal of the American Academy of Dermatology|September 18, 2017
Prior authorizations for dermatologic medications: An American Academy of Dermatology survey of US dermatology providers and staffAaron M Secrest, Maryam M Asgari, Arianne S Kourosh, et al.
Archives of Dermatology|March 18, 2009
Lenalidomide for the treatment of resistant discoid lupus erythematosusAsha Shah, Joerg Albrecht, Zuleika Bonilla-Martinez, et al.
Archives of Dermatology|January 23, 2008
Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgarisVictoria P Werth, David Fivenson, Amit G Pandya, et al.
Archives of Dermatology|August 20, 2008
Quality of life and disease severity in a cutaneous lupus erythematosus pilot studyElizabeth Gaines, Zuleika Bonilla-Martinez, Joerg Albrecht, et al.
Archives of Dermatology|February 20, 2008
The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosusZuleika L Bonilla-Martinez, Joerg Albrecht, Andrea B Troxel, et al.
Pageof 5